Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming

Open access

Published version of a preprint

Abstract

Obsessive compulsive disorder (OCD) is a highly prevalent disorder that causes serious disability. Available treatments leave 40% or more of people with OCD significantly symptomatic. There is an urgent need for novel therapeutic approaches. Mice that carry a homozygous deletion of the SAPAP3 gene (SAPAP3 KO) manifest a phenotype of excessive self-grooming, tic-like head-body twitches and anxiety. These behaviors closely resemble pathological self-grooming behaviors observed in humans in conditions that overlap with OCD. Following a preliminary report that the tryptaminergic psychedelic, psilocybin, may reduce symptoms in patients with OCD, we undertook a randomized controlled trial of psilocybin in 50 SAPAP3 KO mice (28 male, 22 female). Mice that fulfilled inclusion criteria were randomly assigned to a single intraperitoneal injection of psilocybin (4.4 mg/kg), psychedelic mushroom extract (encompassing the same psilocybin dose) or vehicle control and were evaluated after 2, 12, and 21 days by a rater blind to treatment allocation for grooming characteristics, head-body twitches, anxiety, and other behavioral features. Mice treated with vehicle (n = 18) manifested a 118.71 ± 95.96% increase in total self-grooming (the primary outcome measure) over the 21-day observation period. In contrast, total self-grooming decreased by 14.60 ± 17.90% in mice treated with psilocybin (n = 16) and by 19.20 ± 20.05% in mice treated with psychedelic mushroom extract (n = 16) (p = 0.001 for effect of time; p = 0.0001 for time × treatment interaction). Five mice were dropped from the vehicle group because they developed skin lesions; 4 from the psilocybin group and none from the psychedelic mushroom extract group. Secondary outcome measures such as head-body twitches and anxiety all showed a significant improvement over 21 days. Notably, in mice that responded to psilocybin (n = 12) and psychedelic mushroom extract (n = 13), the beneficial effect of a single treatment persisted up to 7 weeks. Mice initially treated with vehicle and non-responsive, showed a clear and lasting therapeutic response when treated with a single dose of psilocybin or psychedelic mushroom extract and followed for a further 3 weeks. While equivalent to psilocybin in overall effect on self-grooming, psychedelic mushroom extract showed superior effects in alleviating head-body twitches and anxiety. These findings strongly justify clinical trials of psilocybin in the treatment of OCD and further studies aimed at elucidating mechanisms that underlie the long-term effects to alleviate excessive self-grooming observed in this study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-024-02786-0

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Prepared with BioRender (https://www.biorender.com/).
Prepared with BioRender (https://www.biorender.com/).CC BY · PubMed Central
Fig. 1 Consort chart showing the structure of the clinical trial.
Fig. 1 Consort chart showing the structure of the clinical trial.CC BY · PubMed Central
Fig. 2 Self-grooming and head-body twitches in SAPAP3 KO mice and wild-type littermates. Comparison of self-grooming parameters (A–D) and head-body twitches (E) in SAPAP3 KO mice (n = 10) and wild-type littermates (n = 10). Bars represent mean + SEM. **p < 0.01; ***p < 0.001; ****p < 0.0001 (Students t-test, two tailed; unequal variance).
Fig. 2 Self-grooming and head-body twitches in SAPAP3 KO mice and wild-type littermates. Comparison of self-grooming parameters (A–D) and head-body twitches (E) in SAPAP3 KO mice (n = 10) and wild-type littermates (n = 10). Bars represent mean + SEM. **p < 0.01; ***p < 0.001; ****p < 0.0001 (Students t-test, two tailed; unequal variance).CC BY · PubMed Central
Fig. 3 % Change in grooming duration over 21 days in SAPAP3 KO mice treated with VEH, PSIL, or PME. Error bars represent SEM. ANOVA for (A) presented in the text. B shows post-hoc comparisons (Sidak) of PSIL and PME to VEH. **p < 0.01; ****p < 0.0001 (versus VEH).
Fig. 3 % Change in grooming duration over 21 days in SAPAP3 KO mice treated with VEH, PSIL, or PME. Error bars represent SEM. ANOVA for (A) presented in the text. B shows post-hoc comparisons (Sidak) of PSIL and PME to VEH. **p < 0.01; ****p < 0.0001 (versus VEH).CC BY · PubMed Central
Fig. 4 Self-grooming and head body twitches in SAPAP3 KO mice over 21 days following treatment with PSIL, PME, or VEH. Self-grooming bouts (A, B) and head body twitches (C, D) in SAPAP3 KO mice over 21 days following treatment with PSIL, PME, or VEH. ANOVA with repeated measures for time course (A, C) presented in the text. B shows post-hoc comparisons (Sidak) of PSIL and PME to VEH. *p < 0.05, **p < 0.01; ***p < 0.001; ****p < 0.0001 (versus VEH).
Fig. 4 Self-grooming and head body twitches in SAPAP3 KO mice over 21 days following treatment with PSIL, PME, or VEH. Self-grooming bouts (A, B) and head body twitches (C, D) in SAPAP3 KO mice over 21 days following treatment with PSIL, PME, or VEH. ANOVA with repeated measures for time course (A, C) presented in the text. B shows post-hoc comparisons (Sidak) of PSIL and PME to VEH. *p < 0.05, **p < 0.01; ***p < 0.001; ****p < 0.0001 (versus VEH).CC BY · PubMed Central
Fig. 5 Treatment response from Day 21-42 of SAPAP3 KO mice that showed an improvement of 10% or more on total grooming score on Day 21. For total grooming score (A), ANOVA with repeated measures that included PSIL and PME groups only showed a significant effect of time (F = 3.09; df 4,76 ; p = 0.002). *p < 0.05, PME vs. PSIL on Days 12 and 42. (Sidak post hoc test). For head-body twitch, ANOVA with repeated measures that included PSIL and PME groups only showed a significant effect of time (F = 4.61; df 4,80 ; p = 0.002) and time × treatment interaction. (F = 3.22; df 4,80 ; p = 0.01).
Fig. 5 Treatment response from Day 21-42 of SAPAP3 KO mice that showed an improvement of 10% or more on total grooming score on Day 21. For total grooming score (A), ANOVA with repeated measures that included PSIL and PME groups only showed a significant effect of time (F = 3.09; df 4,76 ; p = 0.002). *p < 0.05, PME vs. PSIL on Days 12 and 42. (Sidak post hoc test). For head-body twitch, ANOVA with repeated measures that included PSIL and PME groups only showed a significant effect of time (F = 4.61; df 4,80 ; p = 0.002) and time × treatment interaction. (F = 3.22; df 4,80 ; p = 0.01).CC BY · PubMed Central
Fig. 6 Effect of treatment with PSIL or PME on % change from Day 21 in grooming and head-body twitch. Effect of treatment with PSIL or PME on % change from Day 21 in grooming parameters (A, B) and head-body twitch (C) in SAPAP3 KO mice treated on Day 0 with VEH (saline) and on Day 21 with PSIL or PME. For total grooming duration (A) and grooming bouts (B) ****p < 0.0001 vs. Day 21. For head-body twitches (C) ***p < 0.001 vs. Day 21.
Fig. 6 Effect of treatment with PSIL or PME on % change from Day 21 in grooming and head-body twitch. Effect of treatment with PSIL or PME on % change from Day 21 in grooming parameters (A, B) and head-body twitch (C) in SAPAP3 KO mice treated on Day 0 with VEH (saline) and on Day 21 with PSIL or PME. For total grooming duration (A) and grooming bouts (B) ****p < 0.0001 vs. Day 21. For head-body twitches (C) ***p < 0.001 vs. Day 21.CC BY · PubMed Central
Fig. 7 Behavioral tests in SAPAP3 KO mice compared to wild-type littermates. Open field distance traveled (A) Center Duration (B) EPM Open Arm duration (C) and Marble Burying in Wild Type (WT, n = 20) versus SAPAP3 KO mice (HOM, n = 20). ****p < 0.0001 (Students t-test, two-tailed, unequal variance).
Fig. 7 Behavioral tests in SAPAP3 KO mice compared to wild-type littermates. Open field distance traveled (A) Center Duration (B) EPM Open Arm duration (C) and Marble Burying in Wild Type (WT, n = 20) versus SAPAP3 KO mice (HOM, n = 20). ****p < 0.0001 (Students t-test, two-tailed, unequal variance).CC BY · PubMed Central
Fig. 8 Effect pf PSIL and PME on behavioral parameters in SAPAP3 KO mice. Percent change in open field center duration (A), elevated plus Maze open arm duration (B), open field distance traveled (C), and marble burying (D) in SAPAP3 KO mice before and after treatment with VEH, PSIL or PME. ANOVA with repeated measures results given in the text. Post-hoc Sidak tests: For Center Duration: ***p < 0.001 PME after treatment vs. PME before treatment; ###p < 0.001 PME vs. VEH after treatment; ##p < 0.01 PME vs. PSIL after treatment; For EPM Open Arms Duration: *PME after treatment vs. PME before treatment; For Marble Burying ****p < 0.0001 PME after treatment vs. PME before treatment; ****p < 0.0001 PSIL after treatment vs. PSIL before treatment; ####p < 0.0001 PME versus VEH after treatment; ####p < 0.0001 PSIL versus VEH after treatment;.
Fig. 8 Effect pf PSIL and PME on behavioral parameters in SAPAP3 KO mice. Percent change in open field center duration (A), elevated plus Maze open arm duration (B), open field distance traveled (C), and marble burying (D) in SAPAP3 KO mice before and after treatment with VEH, PSIL or PME. ANOVA with repeated measures results given in the text. Post-hoc Sidak tests: For Center Duration: ***p < 0.001 PME after treatment vs. PME before treatment; ###p < 0.001 PME vs. VEH after treatment; ##p < 0.01 PME vs. PSIL after treatment; For EPM Open Arms Duration: *PME after treatment vs. PME before treatment; For Marble Burying ****p < 0.0001 PME after treatment vs. PME before treatment; ****p < 0.0001 PSIL after treatment vs. PSIL before treatment; ####p < 0.0001 PME versus VEH after treatment; ####p < 0.0001 PSIL versus VEH after treatment;.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 36

Metadata

Authors
Brownstien, M., Lazar, M., Botvinnik, A., Shevakh, C., Blakolmer, K., Lerer, L., Lifschytz, T., & Lerer, B.
Affiliations
Hebrew University of Jerusalem (IL)
Corresponding author
  • Lifschytz, Tzuri
  • Lerer, Bernard
Venue
Molecular Psychiatry
Published
2024-10-11
Volume
30
Issue
3
Pages
1172-1183
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W4403328142
Cited by
30
References
39
Citations by year
2026: 15 · 2025: 14 · 2024: 1
FWCI
15.04
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Psychiatry (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
Funders
Parow Emtheobiosciences (ParowBio) Back of the yards algae sciences
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
psilocybin, obsessive-compulsive disorder, anxiety, long-term treatment outcomes, animal model of OCD, treatment-resistant OCD

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming. https://app.cochat.ai/papers/10.1038/s41380-024-02786-0
The paper
Brownstien, M., Lazar, M., Botvinnik, A., Shevakh, C., Blakolmer, K., Lerer, L., Lifschytz, T., & Lerer, B. (2025). Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming. Molecular Psychiatry. https://doi.org/10.1038/s41380-024-02786-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.